AI-driven innovation in antibody-drug conjugate design.
- Published in:
- Frontiers in Drug Discovery, 2025, p. 1, doi. 10.3389/fddsv.2025.1628789
- By:
- Publication type:
- Article
Works matching IS 26740338 AND DT 2025
Results: 12
1
2
Editorial: Pharmacokinetics modeling in the Artificial Intelligence Era.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
3
Dual upregulation of miRNA-143 and miRNA-506 in non-small cell lung cancer inhibits proliferation, motility, migration, and tumor growth.
- Published in:
- Frontiers in Drug Discovery, 2025, p. 1, doi. 10.3389/fddsv.2025.1584801
- By:
- Publication type:
- Article
4
Editorial: Enhancing drug discovery through structure-based design and computational techniques.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
5
Safety and tolerability of a bevacizumab biosimilar (Effivia<sup>®</sup>) in adult Mexican patients with cancer: a multicenter, observational, prospective clinical study.
- Published in:
- Frontiers in Drug Discovery, 2025, p. 1, doi. 10.3389/fddsv.2025.1591991
- By:
- Publication type:
- Article
6
Identification of natural compounds as potential inhibitors of Interleukin-23: virtual screening, ADMET, drug-likeness, and dynamic simulation.
- Published in:
- Frontiers in Drug Discovery, 2025, p. 1, doi. 10.3389/fddsv.2025.1525533
- By:
- Publication type:
- Article
7
Transduction of hematopoietic stem and progenitor cells by an MECP2 lentiviral vector improves Rett syndrome phenotypes.
- Published in:
- Frontiers in Drug Discovery, 2025, p. 1, doi. 10.3389/fddsv.2025.1545391
- By:
- Publication type:
- Article
8
Perspective: How complex in vitro models are addressing the challenges of predicting drug-induced liver injury.
- Published in:
- Frontiers in Drug Discovery, 2025, p. 1, doi. 10.3389/fddsv.2025.1536756
- By:
- Publication type:
- Article
9
Editorial: Exploring drug development with single cell omics analytics and stem cell-based disease models.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
10
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment.
- Published in:
- Frontiers in Drug Discovery, 2025, p. 1, doi. 10.3389/fddsv.2025.1520734
- By:
- Publication type:
- Article
11
Validation of an MPS-based intestinal cell culture model for the evaluation of drug-induced toxicity.
- Published in:
- Frontiers in Drug Discovery, 2025, p. 1, doi. 10.3389/fddsv.2024.1459424
- By:
- Publication type:
- Article
12
Targeting steroid receptor coactivators in cancer via small molecule agents.
- Published in:
- Frontiers in Drug Discovery, 2025, p. 1, doi. 10.3389/fddsv.2024.1514412
- By:
- Publication type:
- Article